Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127087) titled 'Cytology-based AI model for multi-cancer diagnosis and pathological subtyping using expert-independent single-cell annotation' on June 24.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Malignant neoplasms, excluding lymphatic, hematopoietic, central nervous system, or related tissues
Intervention:
Gold Standard:Single-cell sequencing
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-01
Target Sample Size: Target condition:1100;Difficult condition:0
Countries of Recruitment:
China
To know mor...